Sequential designs for dose escalation studies in oncology

DOI10.1080/03610918.2012.625834MaRDI QIDQ4905910zbMATH OpenOpenAlexFDO

Authors Katrin Roth

Publication date 21 February 2013

Published in Communications in Statistics. Simulation and Computation (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/03610918.2012.625834

zbMATH Keywords

dose finding studiesoptimal designsequential design

Mathematics Subject Classification ID

Optimal statistical designs (62K05) Sequential statistical design (62L05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Optimal Bayesian-feasible dose escalation for cancer phase I trials
• scientific article; zbMATH DE number 590042
• The construction of optimal designs for dose-escalation studies
• A new look at evaluating MTD designs in cancer research
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer

Cites work

• Bayesian decision procedures based on logistic regression models for dose-finding studies
• Dose finding in drug development.
• scientific article; zbMATH DE number 3522963 (Why is no real title available?)

Cited in

(7)

• Optimal Bayesian-feasible dose escalation for cancer phase I trials
• On optimal designs for clinical trials: an updated review
• Adaptive clinical trial designs for phase I cancer studies
• scientific article; zbMATH DE number 590042 (Why is no real title available?)
• Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
• Review of Statistical Treatment for Oncology Dose-Escalation Trial with Prolonged Evaluation Window or Fast Enrollment
• Retrospective Analysis of Sequential Dose‐Finding Designs

This page was built for publication: Sequential designs for dose escalation studies in oncology

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4905910)